Moderna
42°21′48″N 71°05′28″W / 42.3633°N 71.091°W
Former headquarters in Cambridge, Massachusetts | |
| Formerly | ModeRNA Therapeutics (2010–2018) |
|---|---|
| Company type | Public |
| ISIN | US60770K1079 |
| Industry | Biotechnology |
| Founded | September 2010 |
| Founders |
|
| Headquarters | Cambridge, Massachusetts, U.S. |
Key people | |
| Products |
|
| Revenue | US$3.24 billion (2024) |
| US$−3.9 billion (2024) | |
| US$−3.6 billion (2024) | |
| Total assets | US$14.1 billion (2024) |
| Total equity | US$10.9 billion (2024) |
| Owners |
|
Number of employees | 5,800 (2024) |
| Website | modernatx |
| Footnotes / references [1][2][3] | |
Moderna, Inc. (/məˈdɜːrnə/ mə-DUR-nə)[4] is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response.[5][1] The company's name is derived from the terms "modified", "RNA", and "modern".[6][7][8]
The company's commercial products are the Moderna COVID-19 vaccine, marketed as Spikevax and a respiratory syncytial virus vaccine, marketed as Mresvia. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.[1]
- ^ a b c "Moderna, Inc., 2024, Form 10-K Annual Report". U.S. Securities and Exchange Commission. February 21, 2025.
- ^ "Moderna, Inc. Schedule 14A 2022 Proxy Statement". U.S. Securities and Exchange Commission. March 9, 2022.
- ^ "Key Facts". Moderna.
- ^ Moderna (October 23, 2019). mRNA-3704 and Methylmalonic Acidemia (video) – via YouTube.
- ^ Park KS, Sun X, Aikins ME, Moon JJ (December 2020). "Non-viral COVID-19 vaccine delivery systems". Advanced Drug Delivery Reviews. 169: 137–51. doi:10.1016/j.addr.2020.12.008. PMC 7744276. PMID 33340620.
- ^ "Moderna, Our story; Our big moments". Moderna, Inc. 2023. Retrieved February 10, 2023.
- ^ Garde D, Saltzman J (November 10, 2020). "The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race". Stat. Archived from the original on November 10, 2020.
- ^ Servick K (March 25, 2020). "This mysterious $2 billion biotech is revealing the secrets behind its new drugs and vaccines (from the original, 1 February 2017)". Science. doi:10.1126/science.aal0686. S2CID 241466550.